MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.58
-0.01 (-1.30%)
As of Oct 3, 2:22 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +3,234.5% upside
Low Target $16.83
Average Target $19.24
High Target $29.48
Current Price $0.58
Current
$0.58
Target
$19.24
$16.83 $19.24 avg $29.48
Scenario Analysis
Bear Case
$16.83
2,816.8%
Low target
Base Case
$19.24
+3,234.5%
Avg target
Bull Case
$29.48
+5,009.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.33
-89.2% from high
52-Week Low
$0.40
+44.3% from low
Target vs 52W High
$19.24
+261.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -52.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +150.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -13.2%
MRNA
Moderna Inc
Hold 30 37% $149.45 -21.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.8%